皮质类固醇对腹壁下动脉穿支皮瓣因吻合口血栓再次探查后缺血再灌注损伤的影响:一项前瞻性随机试验
该双盲前瞻性随机试验于2012年1月至2023年1月纳入46例接受二期单侧腹壁下动脉穿支皮瓣乳房再造、术后发生静脉或动脉血栓并再次手术行吻合口翻修后出现缺血再灌注损伤的患者,治疗组接受5天皮质类固醇疗程,对照组未接受特定治疗。治疗组仅1例部分皮瓣坏死,对照组2例全皮瓣坏死、8例部分皮瓣坏死(p<0.05);治疗组缺血再灌注损伤临床体征完全消退时间13±2.1天 vs 对照组21±3.5天(p=0.00001),住院时间11.13±0.38天 vs 15.47±1.27天(p<0.0001)。作者认为靶向皮质类固醇治疗在皮瓣血管血栓挽救术后对缺血再灌注损伤显示出前景,可考虑作为游离皮瓣缺血再灌注损伤的处理选项,但需更大样本研究证实。
要点
- 治疗组部分皮瓣坏死1例,对照组全皮瓣坏死2例、部分皮瓣坏死8例(p<0.05)。
- 缺血再灌注损伤临床体征完全消退治疗组13±2.1天 vs 对照组21±3.5天(p=0.00001)。
- 住院时间治疗组11.13±0.38天 vs 对照组15.47±1.27天(p<0.0001)。
核心结论
- 腹壁下动脉穿支皮瓣血管血栓挽救术后靶向皮质类固醇治疗对后续缺血再灌注损伤显示出前景,作者认为可考虑作为游离皮瓣缺血再灌注损伤的处理选项,但需更大样本研究证实。
研究设计与样本
- 双盲前瞻性随机试验,2012年1月至2023年1月纳入46例计划行二期单侧腹壁下动脉穿支皮瓣乳房再造的患者。
- 纳入条件为术后发生静脉或动脉皮瓣血栓、再次手术行吻合口翻修后出现腹壁下动脉穿支皮瓣缺血再灌注损伤。
- 治疗组接受5天皮质类固醇疗程,对照组未接受任何特定治疗。
主要发现
- 对照组观察到2例全皮瓣坏死和8例部分皮瓣坏死,治疗组仅1例部分皮瓣坏死(p<0.05)。
- 缺血再灌注损伤临床体征完全消退时间治疗组13±2.1天 vs 对照组21±3.5天(p=0.00001)。
- 住院时间治疗组11.13±0.38天 vs 对照组15.47±1.27天(p<0.0001)。
临床怎么用
- 作者认为腹壁下动脉穿支皮瓣血管血栓挽救术后靶向皮质类固醇治疗可考虑作为游离皮瓣缺血再灌注损伤的处理选项。
局限性
- 原文指出需要更大样本量的进一步研究来证实作者的假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients undergoing breast reconstruction with the deep inferior epigastric perforator (DIEP) flap are at risk of arterial and venous thrombosis, necessitating flap salvage surgery. However, this carries the risk of ischemia-reperfusion injury (IRI) and potential significant partial or complete flap loss. The objective of this study was to evaluate the potential benefit of corticosteroids in reducing IRI related complications in DIEP flaps that are returned to the operation theater for attempted salvage after venous or arterial failure. A double-blinded prospective randomized study was conducted between January 2012 and January 2023 on patients scheduled for secondary unilateral breast reconstruction using the DIEP flap technique. Patients were included if they developed post-operative venous or arterial flap thrombosis and experienced DIEP flap IRI following operative take-back and anastomosis revision. The treatment group (TG) received a 5-day course of corticosteroids, while the control group (CG) did not receive any specific treatment. Forty-six patients were enrolled in the study. In the CG, two cases of total flap loss and eight cases of partial flap necrosis were observed, while the TG had only 1 case of partial flap necrosis (p < 0.05). The complete resolution of clinical signs of IRI occurred within 13 ± 2.1 days for the TG and 21 ± 3.5 days for the CG (p = 0.00001). The TG had a significantly shorter hospital stay (11.13 ± 0.38 days) compared with the CG (15.47 ± 1.27 days; p < 0.0001). Targeted corticosteroid therapy following a salvage procedure for vascular thrombosis in DIEP flaps has shown promise as an effective treatment for subsequent IRI. This approach may be considered as a viable option for managing IRI in free flaps. However, further studies involving a larger number of patients are required to substantiate our hypothesis.
引用
- La Padula S, Bufalino PM, Bosc R, et al. Effect of corticosteroids on ischemia-reperfusion injury of deep inferior epigastric perforator flap after re-exploration for anastomosis thrombosis: A prospective randomized trial. J Plast Reconstr Aesthet Surg. 2024. PMID: 38493540. doi:10.1016/j.bjps.2024.02.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。